Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Tianchen International Medical Technology Co., Ltd. was established in August 2003 and is a high-tech enterprise specializing in the research and development, innovation, production and sales of high-end surgical staplers. Through continuous independent research and innovation over the past 17 years, the company has five major categories of products: tubular staplers, endoscopic staplers, linear cutting staplers, pocket staplers, and linear suture staplers. The application scope covers surgical fields such as cardiothoracic surgery, gastrointestinal surgery, hepatobiliary splenopancreatic surgery, general surgery, and urology. The company adheres to the approach of "independent innovation, research and development first, and patent layout", and develops products with independent intellectual property rights. The research and innovation achievements are fruitful, and corresponding patent layouts have been implemented both domestically and internationally. As of the end of 2019, the company has 380 domestic and foreign patents, including 228 invention patents, covering countries and regions such as China, Europe, the United States, Japan, etc., effectively breaking through the intellectual property barriers that American medical device giants have monopolized in this field for many years, and becoming a leading enterprise in the export of high-end surgical staplers in China. The company always adheres to high-quality R&D investment, including talent introduction, patent layout, and improved R&D experimental facilities, continuously improving innovation and R&D capabilities, and continuously outputting new products that are technologically advanced and in line with market development trends. The company has established a complete and comprehensive quality management system in strict accordance with relevant regulations and standards, covering the entire process of quality management from product development to production, sales, and after-sales. It has also obtained certifications from relevant organizations such as the European Union, Brazil, and South Korea. The company will continue to strive to create more clinically valuable and high-quality stapler products, committed to becoming an innovative and production base for high-end surgical staplers.
Headquarter Suzhou
Establish Date 8/18/2003
Listed Code 688013.SH
Listed Date 9/28/2020
Chairman Chen Wangyu.
CEO Chen Wangdong.
Website www.touchstonesurgical.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial